According to Innova Market Insights, the use of cardiovascular impact claims in F&B product and supplement launches is decreasing globally, with a marked -10% year-over-year decline when comparing 2020/Q4 – 2021/Q3 and 2021/Q4 – 2022/Q3 launches. Supplements is top category of global product launches tracked with cardiovascular impact claims at 62% and vitamin C is the leading ingredient among the cardiovascular impact claims at 14%. The top positionings paired with mobility were brain-mood health, immune health and energy and stamina.